Strategy for the reduction of stroke incidence in cardiac surgical patients.
Strategy for the reduction of stroke incidence in cardiac surgical patients.
复制标题
降低心脏手术患者中风发生率的策略。
DOI:
10.1016/0003-4975(93)91079-3
复制
发表时间:
1993
期刊:
影响因子:
--
通讯作者:
Kouchoukos,NT
中科院分区:
文献类型:
--
作者:
Wareing,TH;Davila-Roman,VG;Daily,BB;Murphy,SF;Schechtman,KB;Barzilai,B;Kouchoukos,NT
Atherosclerosis of the ascending aorta (AAA) and severe carotid artery disease are risk factors for stroke in cardiac surgical patients. Twelve hundred of a consecutive series of 1,334 patients 50 years of age or older having a cardiac operation were screened for the presence of AAA by intraoperative ultrasonographic scanning and for the presence of carotid artery occlusive disease (791 of 798 patients ≥65 years of age and younger symptomatic patients) by carotid duplex scanning. Coronary artery disease was present in 88% of the patients. Patients with moderate or severe AAA (n = 231; 19.3% of the total) were treated by ascending aortic replacement (n = 27) or by modified, less extensive techniques (n = 168) to avoid the atherosclerotic areas. Thirty-three patients had combined carotid endarterectomy and cardiac operation. Thirty-day mortality and stroke rates for the 1,200 patients were 4.0% and 1.6%, respectively. The stroke rate was low (1.1%) among the 969 patients with no or mild AAA. It was zero among 27 patients with moderate or severe AAA who had ascending aortic replacement and among the 33 patients who had carotid endarterectomy. The stroke rates were higher for 111 patients with moderate or severe ascending aortic disease who had only minor interventions (6.3%) and for 16 patients with severe carotid artery disease who did not have carotid endarterectomy (18.7%). Screening for AAA and carotid artery disease and aggressive surgical treatment of moderate or severe AAA and severe or symptomatic carotid artery disease appears to reduce the frequency of stroke in older cardiac surgical patients.
登录
查看更多内容
DOI:
10.1172/jci110931
发表时间:
1983-06
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
L. Scharschmidt;M. Dunn
通讯作者:
L. Scharschmidt;M. Dunn
影响因子:
4.4
作者:
G. Nedwin;L. P. Svedersky;T. Bringman;M. Palladino;D. Goeddel
通讯作者:
D. Goeddel
DOI:
10.1016/b978-0-323-37677-8.50020-6
发表时间:
2006
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
P. Gardner;J. Mcquillin;S. Court
通讯作者:
S. Court
影响因子:
11.2
作者:
P. Harris;P. Ralph;P. Litcofsky;M. Moore
通讯作者:
M. Moore
DOI:
--
发表时间:
1984
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Welliver,RC;Kaul,TN;Sun,M;Ogra,PL
通讯作者:
Ogra,PL